Valuation: Abbott Laboratories

Market Cap 187B 162B 152B 139B 262B 17,795B 266B 1,776B 697B 8,891B 701B 686B 29,594B P/E 2026 *
31x
P/E 2027 * 23.8x
Enterprise Value 211B 183B 171B 157B 296B 20,097B 300B 2,006B 787B 10,041B 792B 775B 33,422B EV / Sales 2026 *
4.19x
EV / Sales 2027 * 3.81x
Free-Float
86.16%
Yield 2026 *
2.38%
Yield 2027 * 2.52%
1 day+1.31%
1 week+2.78%
Current month+2.78%
1 month+10.17%
3 months+26.16%
6 months+0.41%
Current year-10.86%
1 week 91.04
Extreme 91.04
94.04
1 month 77.38
Extreme 77.38
95.42
Current year 69.76
Extreme 69.76
109.34
1 year 69.76
Extreme 69.76
116.8
3 years 69.76
Extreme 69.76
133.78
5 years 69.76
Extreme 69.76
133.78
10 years 34.46
Extreme 34.461
133.78
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
+1.31%+2.78% - - 187B
+2.13%+2.23%-17.54%+0.29% 187B
-0.08%+0.25%-3.85%+2.24% 110B
+2.46%+4.09%+14.53%+75.37% 62.02B
+0.65%+3.91%+37.08%+53.44% 53.79B
+3.76%+7.02%+2.70%-34.61% 48.79B
-5.88%-11.78% - - 30.27B
+0.44%+11.38%+8.66%-31.01% 31.33B
-0.69%+2.65%+46.92%-7.06% 24.53B
-0.40%+0.25%+4.78%+2.55% 22.59B
Average +0.06%+2.42%+11.66%+7.65% 63.35B
Weighted average by Cap. +0.49%+2.55%+1.59%+9.40%

Financials

2026 *2027 *
Net sales 50.3B 43.65B 40.88B 37.39B 70.59B 4,792B 71.51B 478B 188B 2,394B 189B 185B 7,969B 54.65B 47.42B 44.41B 40.62B 76.69B 5,206B 77.69B 520B 204B 2,601B 205B 201B 8,657B
Net income 6.23B 5.41B 5.06B 4.63B 8.74B 594B 8.86B 59.23B 23.25B 297B 23.39B 22.88B 987B 7.93B 6.89B 6.45B 5.9B 11.13B 756B 11.28B 75.43B 29.6B 378B 29.79B 29.14B 1,257B
Net Debt 24.17B 20.97B 19.64B 17.96B 33.91B 2,302B 34.35B 230B 90.16B 1,150B 90.73B 88.76B 3,828B 21.42B 18.58B 17.4B 15.92B 30.05B 2,040B 30.45B 204B 79.9B 1,019B 80.41B 78.66B 3,393B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
07/08/26 94.04 +1.97% 15
06/08/26 €92.22 +1.14% 16
05/08/26 €91.18 -0.68% 50
04/08/26 €91.80 -1.16% 305
03/08/26 €92.88 +1.51% 55
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
107.96USD
Average target price
118.42USD
Spread / Average Target
+9.69%

Quarterly revenue - Rate of surprise